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OBJECTIVE: The aim of the present study was to prospectively, randomly, blindly, and objectively investigate
how surgery affects plantar sudoresis in patients with palmar and plantar hyperhidrosis over a one-year period
using a sudorometer (VapoMeter).
METHODS: From February 2007 to May 2009, 40 consecutive patients with combined palmar hyperhidrosis and
plantar hyperhidrosis underwent video-assisted thoracic sympathectomy at the T3 or T4 ganglion level (15
women and 25 men, with a mean age of 25 years).
RESULTS: Immediately after the operation and during the one-year follow-up, all of the patients were free
from palmar hyperhidrosis episodes. Compensatory hyperhidrosis of varying degrees was observed in 35
(87.5%) patients after one year. Only two (2.5%) patients suffered from severe compensatory hyperhidrosis.
There was a large initial improvement in plantar hyperhidrosis in 46.25% of the cases, followed by a progressive
regression of that improvement, such that only 30% continued to show this improvement after one year. The
proportion of patients whose condition worsened increased progressively (from 21.25% to 47.50%), and the
proportion of stable patients decreased (32.5% to 22.50%). This was not related to resection level; however, a
lower intensity of plantar hyperhidrosis prior to sympathectomy correlated with worse evolution.
CONCLUSION: Patients with palmar hyperhidrosis and plantar hyperhidrosis who underwent video-assisted
thoracic sympathectomy to treat their palmar hyperhidrosis exhibited good initial improvement in plantar
hyperhidrosis, which then decreased to lesser degrees of improvement over a one-year period following the
surgery. For this reason, video-assisted thoracic sympathectomy should not be performed when only plantar
hyperhidrosis is present.
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& INTRODUCTION
Plantar hyperhidrosis (PLH) is a very common complaint
(1) and is usually associated (more than 80% of cases) with
palmar hyperhidrosis (PH) (2). Patients undergoing thoracic
sympathectomy to treat palmo-plantar hyperhidrosis (HH)
recover with anhidrosis of the hands in more than 95% of
cases (3), thereby improving their quality of life (QOL) (4).
The few studies on the evolution of feet sweating after
thoracic sympathectomy have been based on subjective
evaluations. The patients reported good initial improvement
in PLH immediately after surgery; however, this improve-
ment subsided over the one-year period following surgery
(5,6).
Tests for the objective quantification of sweating have
been developed (7,8,9,10). Recently, a device known as a
VapoMeter has been used to quantify the diffusion of water
vapor through the skin under controlled conditions of
temperature and humidity. We used this device to assess
the outcomes of treatment for primary palmar HH by video-
assisted thoracoscopic sympathectomy (VATS) in 40
patients (11).
There are no studies of long-term sweating of the feet
using objective evaluation of sudoresis in patients with
palmoplantar HH submitted to thoracic sympathectomy.
The aim of the present study was to prospectively and
objectively investigate how surgery affects plantar sudoresis
in the feet of patients with palmo-plantar HH over a one-
year period using a sudorometer (VapoMeter).
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& METHODS
From February 2007 to May 2009, 40 patients with
combined palmar and plantar hyperhidrosis underwent
VATS (15 women and 25 men, with a mean age of 25 years)
in a prospective, randomized, blind, and controlled study
according to the guidelines of the Ethics Committee for
Analysis of Research Projects on Human Experimentation at
our institution. None of these patients exhibited HH in other
parts of the body. In addition to these patients with HH, we
also evaluated 20 healthy participants (10 men and 10
women) without any previous history of hyperhidrosis to
form a control group (CON), which served as a reference
and comparison standard when following the subjects who
underwent the operation. The demographic data are
described in Table 1.
The patients underwent VATS at two levels: 20 patients at
the T3 ganglion level and 20 patients at the T4 level. All of
the procedures were performed by the same surgical team
using stable surgical techniques throughout the study.
The patients were informed that they would be subjected
to one of two levels of VATS routinely used in our group: T3
or T4. Randomization was performed by a computer-
generated list prior to the beginning of the protocol. This
list remained confidential and under possession of a single
person who did not participate in the study. The inclusion
of patients in groups T3 and T4 was announced to the team
immediately prior to the operation.
All patients underwent surgery under general anesthesia
in a semi-seated position while inclined at 45 .˚ Two 5 mm
mini-incisions were made: the first at the fourth intercostal
space on the anterior axillary line, into which the thoraco-
scope was introduced, and the second at the second
intercostal space on the medial axillary line, into which an
electric or harmonic cautery was introduced. For sym-
pathectomy at the T3 ganglion level, after identification of
the sympathetic chain, the patients underwent resection of
the chain (sympathicotomy) on the body of the third (R3)
and fourth ribs (R4), followed by thermoablation of the
segment isolated between them (the ribs). For the T4
ganglion level, the patients underwent sympathicotomy on
the body of the fourth (R4) and fifth ribs (R5), followed by
thermoablation of the segment isolated between them (the
ribs). The same procedure was performed on the contral-
ateral chain at the same level in all cases.
Immediately after the operation and during the one-year
follow-up, none of the patients reported any episodes of
palmar hyperhidrosis. There was no mortality, and it was
not necessary to convert the videothorascopic procedure
into an open surgery in either of the groups.
The outpatient evaluation, quantification of sweat, and
application of the QOL questionnaire were performed by an
independent observer who did not participate in the
operation and had no knowledge of the level of surgical
intervention. The team responsible for the operative
procedures did not participate in any phase of the out-
patient evaluations. The level of the thermoablated ganglion
was revealed to the patients only after completing one year
of follow-up.
Six patients exhibited slight/weak pleural adherences,
which were detached using an endoscopic scalpel. Only one
patient had a right-side residual pneumothorax (2.5%)
during the immediate postoperative period, which
amounted to less than 10% and did not require pleural
drainage. One patient had paresthesia (2.5%) in the upper
right limb, which regressed within the first month of follow-
up.
Compensatory HH was observed in varying degrees in 35
patients (87.5%) after one year. Only two (2.5%) patients
suffered from severe compensatory HH.
The patients’ PLH complaints were investigated using a
VapoMeter, a noninvasive, portable instrument (Delfin
Technologies Ltd., Kuopio, Finland). This device measures
transepidermal water loss (TEWL) using a closed measure-
ment chamber that eliminates external interference from air
currents. The instrument is placed on the skin and
maintains contact with the skin surface for approximately
10 seconds. The evaporation rate is calculated from the rise
in relative air humidity inside the closed chamber of the
device, and this value is quantified in g/m2/h (increase in
the water mass per unit of evaporation area per unit of
time).
The measurements were performed at the HH outpatient
clinic in a climate-controlled room at a temperature between
21 and 24 C˚, independent of the season of the year. All of
the patients remained at rest for 20 to 30 minutes prior to the
measurements to reduce external influences. The measure-
ments were made on the plantar face (Figure 1).
Objective quantification of plantar sweating was per-
formed using the VapoMeter prior to the operation and at
one week, one month, six months, and one year after the
operation. In the control group, we performed only one
quantification of sweating in the same location. The
principal investigator performed all of the evaluations.
We performed two types of objective assessments of PLH.
First, we evaluated the average plantar sweating in each
group of patients before surgery and at seven days, 30 days,
six months, and one year after surgery.
Second, each foot was evaluated, and the changes in the
measurements for sweating were compared over time. In
this second analysis, we compared the values obtained at
the time points after the surgery with the values obtained
prior to surgery. We considered sudoresis to be improved
for each period when the values were 25% lower than the
initial value for the same foot; worse when the values were
25% greater than the initial value; and stable when the
values changed by less than 25% from the original
measurement.
Finally, we studied the relationship between the level of
resection and the evolution of the amount of sudoresis for
each foot after surgery. We empirically considered 41.5 g/
m2/h as the maximum reference value for normal sudoresis
(25% greater than baseline).
Table 1 - Demographic data from patients in both groups.
Control Plantar hyperhidrosis undergoing T3 Plantar hyperhidrosis undergoing T4
Age (mean ¡ SD) 25.8¡7.0 25.1¡5.5 25.0¡7.1
Body mass index 22.3¡2.9 21.8¡1.4 23.0¡1.4
Gender (male:female) 10:10 7:13 8:12
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Statistical Analysis
For the variable age, a one-way analysis of variance
(ANOVA) test was used. For gender, the x2 test was used.
For the pre-operative and post-operative (at one week, one
month, six months, and one year) evaporation rates of the
feet in the T3 and T4 ganglia groups, a two-way ANOVA
was used. The Bonferroni multiple comparisons test was
applied when a statistically significant difference was
detected.
The Friedman test was used to assess the association
between HH outcomes at seven days, one month, six
months, and one year.
The chi-square frequency test was used for comparisons
between T3 and T4 at each time point. The level of statistical
significance was set to 5%.
& RESULTS
Objective quantifications of average plantar sweating
prior to the operation and at one month, six months, and
one year after the operation are presented in Table 2
according to the resection level.
There were significant differences between the control
group (27.69) and patients with HH (64.04 and 56.84)
(p,0.01) (Table 2). However, there was no difference
between the levels of resection in the different periods.
Analyses of the amount of sweating for each foot at one
week, one month, six months, and one year after the
operation are presented in Table 3.
A total of 37 feet (46.25%) showed an initial improvement
in plantar hyperhidrosis, followed by a progressive regres-
sion of the improvement, such that the improvement was
sustained in only 30% of feet after one year. The proportion
of feet whose condition worsened increased progressively
(from 21.25% to 47.50%), and the proportion of stable
patients decreased (32.5% to 22.50%).
Table 4 displays the changes in the amount of sweat for
each foot according to the resection level (T3 and T4) at one
week, one month, six months, and one year after the
operation.
Both groups showed similar changes in the amount foot
sweating over time, the first month being the only
exception, which was not maintained.
Table 5 presents the changes in sudoresis for each foot
according to the amount of sweat prior to surgery (either
less than 41.5 g/m2/h or greater than 41.5 g/m2/h) at the
different time points after the operation.
After one week, we observed that the feet that previously
exhibited more sweating (greater than 41.5 g/m2/h) had a
higher rate of improvement and stability and a lower rate of
deterioration compared with the feet that exhibited less
sweating. After one year, only five feet with less sweating
had improved, and 54.2% were worse. For the group with the
most sweating, 32.2% improved, 44.6% worsened, and 23.2%
were stable.
& DISCUSSION
The surgical method of choice for treating HH is VATS,
which most frequently involves resections of the third or
fourth ganglion for the treatment of PH (12).
Figure 1 - Location for the measurement of the feet.
Table 2 - Mean plantar sweating before and after
sympathectomy.
Control T3 T4
BEFORE 27.69 64.04 56.84
1 MONTH 53.60 66.44
6 MONTHS 60.82 73.71
12 MONTHS 86.78 64.98
Table 3 - Evolution of the amount of sudoresis for each
foot over time.
7 Days 1 Month 6 Months 12 Months
IMPROVED 37 (46.25) 31 (38.75) 29 (36.25) 24 (30.00)
STABLE 26 (32.5%) 19 (23.75%) 20 (25.00%) 18 (22.50%)
WORSE 17 (21.25) 30 (27.5) 31 (38.75) 38 (47.50)
Friedman p=0.1738.
Table 4 - Changes in the amount of sudoresis for each
foot according to the resection level (T3 and T4) over time
(in this table, patients are analyzed, not individual feet).
Time point Status T3 Freq. (%) T4 Freq. (%) p-value
7 Days Improved 20 (50.0) 17 (42.5) 0.340
Stable 10 (25.0) 16 (40.0)
Worse 10 (25.0) 7 (17.5)
1 Month Improved 15 (37.5) 16 (40.0) 0.040
Stable 14 (35.0) 5 (12.5)
Worse 11 (27.5) 19 (47.5)
6 Months Improved 17 (42.5) 12 (30.0) 0.509
Stable 9 (22.5) 11 (27.5)
Worse 14 (35.0) 17 (42.5)
12 Months Improved 10 (25.0) 14 (35.0) 0,398
Stable 8 (20.0) 10 (25.0)
Worse 22 (55.0) 16 (40.0)
p-value obtained from the chi-square frequency test.
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When the resection level is higher (T3), hands will exhibit
less sweating; when the resection level is lower, there is a
reduced likelihood that the patient will present with
compensatory HH (13,14,15). This procedure is safe and
has a low complication rate (16,17,18,19), as confirmed by
our study, where the patients did not experience any
repercussions. In this case series, 40 consecutive bilateral
sympathectomies were performed, and we obtained full
success in all cases in terms of improving hand sudoresis.
Compensatory HH (13,14) is the most frequent and
important problem related to VATS. At level T3 and
especially at level T4, HH is less severe than at level T2 (15).
Usually, patients with HH have excessive sweating in
more than one location. In this study, we analyzed 40
patients with HH in the hands and feet, which is the most
common combination. In many situations, PLH levels can
be as great as or greater than PH levels (20). In patients with
PLH as the primary complaint, lumbar sympathectomy is
the treatment of choice (21), which was not the case in this
study because PH was the principal complaint of every
patient, whereas PLH was secondary.
In this study, we obtained data through an objective
method previously used and validated for the measurement
of sweating in humans (22). In previously published studies
that evaluated the results of sympathectomy in the treat-
ment of PLH, most of the data were based on the patients’
subjective reports (4,5). Although the subjective data were
most often associated with the perception of sudoresis and
with satisfaction after surgery, objective data for compar-
ison with previously published studies (11) were rarely
obtained.
Because we observed that there was great variability in
the extent of sweating between the two feet of a single
individual (there was disagreement in 15 patients), we
decided to evaluate the variations of sweating by foot and
not by individual.
We initially analyzed the average of the objective values
for each group and observed that on average, the TEWL
rates for the T3 and T4 ganglion groups were higher than
those in the control group, which provides objective
evidence. After surgery, on average, we did not observe
significant changes over time regarding the persistence of
PLH. These analyses were not significant because the
standard deviation in each case was high. Additionally,
with this type of analysis, we could not determine the
individual repercussions of feet sudoresis over time, which
is why we decided to analyze the changes in sudoresis for
each foot. We used the original measurement for each foot
and compared it with the subsequent measurement for each
patient using the initial measurement as the point of
reference. We defined three possibilities for each case:
improvement when the levels were 25% higher than the
initial levels, worsening when they were 25% lower than the
initial levels, and stability when the values were inter-
mediate.
In our series, 46.25% of the patients had an improvement
in their foot HH one week after VATS, and 30% reported
improvement one year after VATS. This objective result was
similar to the results of previous subjective studies. In a
previous study by our group (5), we found a significant
improvement in 23.4% of patients and only one case of cure
(1.4%) based on subjective data. Hsu et al. (23) reported
better results, with improvement in 64% of patients after
sympathectomy at the T2 level using a subjective method of
analysis.
This large initial improvement, which has also been
described by other authors (5,6), and the subsequent
worsening have no convincing anatomical or physiological
explanations. The improvements were likely a result of
stress reduction caused by the patients’ postoperative
palmar anhidrosis, which may have caused an improve-
ment in the patients’ emotional states. This new situation
may break the negative feedback loop that might be leading
to plantar sweating.
The worsening of PLH over time (an increase in the
proportion of patients with no improvement from 21.25% to
47.50%) may be related to the return of the emotional stress
that was initially lessened because of the high degree of
satisfaction obtained from postoperative palmar anhidrosis
and to the effect of compensatory HH.
After analyzing the effect of thoracic sympathectomy on
PLH and taking the resection level into consideration, we
observed a decrease in improvement in the T3 group from
50% to 25% and a decrease in the T4 group from 42.5% to
35.0%.
A comparison of PLH prior to surgery and at one month
after treatment revealed that a lower intensity of HH before
sympathectomy resulted in a poorer outcome. Similar data
were observed for patient satisfaction after sympathectomy
in a previous study, in which a worse preoperative QOL for
patients undergoing sympathectomy to treat primary
Table 5 - Changes in the amount of sudoresis for each foot over time according to the amount of sudoresis prior to
surgery. Values less than or greater than 41.5 were compared.
Time point Status Less than 41.5 Freq. (%) Greater than 41.5 Freq. (%) p-value
7 Days Improved 8 (33.3) 29 (51.8) 0.002
Stable 5 (20.8) 21 (37.5)
Worse 11 (45.9) 6 (10.7)
1 Month Improved 7 (29.2) 24 (42.9) 0.498
Stable 7 (29.2) 12 (21.4)
Worse 10 (41.6) 20 (35.7)
6 Months Improved 7 (29.2) 22 (39.3) 0.400
Stable 5 (20.8) 15 (26.8)
Worse 12 (50.0) 19 (33.9)
12 Months Improved 5 (20.8) 18 (32.2) 0.579
Stable 6 (25.0) 13 (23.2)
Worse 13 (54.2) 25 (44.6)
p-value obtained by the chi-square test.
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hyperhidrosis reflected a better postoperative improvement
in QOL (24).
The innervations of the legs and feet are well known. The
preganglionic fibers arise from the spinal medulla at its lower
thoracic segment and from the first and second lumbar
segments (T10 to L2), and they subsequently cross over to the
corresponding ganglions of the sympathetic chain. These
fibers progress down the chain and form synapses with the
postganglionic neurons located between the fourth lumbar
ganglion and third sacral ganglion, from which the post-
ganglionic fibers arise and become incorporated into the
nerve branches of the sacral plexus to innervate the lower
extremities (25). Although the results presented in this case
series cannot be explained by our current scientific knowl-
edge, it is important to have such data so that comprehensive
information can be provided to patients prior to VATS.
Patients with palmar and plantar hyperhidrosis who
underwent VATS to treat their palmar hyperhidrosis
exhibited good initial improvement in plantar hyperhidro-
sis, which was not sustained over a one-year period
following surgery. For this reason, VATS should not be
considered when only plantar hyperhidrosis is present.
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